HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of the oligomycin-sensitivity properties of the F1F0-ATPase in mitochondria from rats infected with the liver fluke Fasciola hepatica.

Abstract
The F1F0-ATPase activity of liver mitochondria isolated from rats infected with Fasciola hepatica at 3 and 4 weeks post-infection showed a marked loss of sensitivity to oligomycin and to N,N'-dicyclohexylcarbodiimide. A loss of sensitivity to diethylstilbestrol was also demonstrated at 4 weeks post-infection. Recovery was apparent in most cases by 6 weeks post-infection. No significant difference in latent ATPase activity was observed between mitochondria from control and infected livers at any stage of the infection. The mitochondria from infected livers were therefore considered to have a full complement of the F1 moiety of the F1F0-ATPase complex. Purification of the mitochondrial ATPase from 4-week infected livers resulted in a very low yield of an oligomycin-insensitive complex. This was due to a failure to enrich specific activity during purification. The evidence presented indicates that infection with Fasciola hepatica gives rise to alterations in the function of the host liver mitochondrial ATPase, namely loss of inhibitor sensitivity and apparent structural alterations of the ATPase complex.
AuthorsL M Lenton, C A Behm, F L Bygrave
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1186 Issue 3 Pg. 237-42 (Jul 29 1994) ISSN: 0006-3002 [Print] Netherlands
PMID8043595 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligomycins
  • Dicyclohexylcarbodiimide
  • Diethylstilbestrol
  • Proton-Translocating ATPases
Topics
  • Animals
  • Dicyclohexylcarbodiimide (pharmacology)
  • Diethylstilbestrol (pharmacology)
  • Fascioliasis (enzymology)
  • Male
  • Mitochondria, Liver (enzymology)
  • Oligomycins (pharmacology)
  • Proton-Translocating ATPases (chemistry, isolation & purification, metabolism)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: